353 related articles for article (PubMed ID: 37274287)
1. The multidisciplinary approach to eosinophilia.
Thomsen GN; Christoffersen MN; Lindegaard HM; Davidsen JR; Hartmeyer GN; Assing K; Mortz CG; Martin-Iguacel R; Møller MB; Kjeldsen AD; Havelund T; El Fassi D; Broesby-Olsen S; Maiborg M; Johansson SL; Andersen CL; Vestergaard H; Bjerrum OW
Front Oncol; 2023; 13():1193730. PubMed ID: 37274287
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. A retrospective cohort study of patients with eosinophilia referred to a tertiary centre.
Hougaard M; Thomsen GN; Kristensen TK; Lindegaard HM; Davidsen JR; Hartmeyer GN; Kjeldsen AD; Martin-Iguacel R; Maiborg M; Assing K; Andersen CL; Broesby-Olsen S; Møller MB; Vestergaard H; Bjerrum OW
Dan Med J; 2022 Mar; 69(4):. PubMed ID: 35319447
[TBL] [Abstract][Full Text] [Related]
4. Hypereosinophilic syndrome in the differential diagnosis of pulmonary infiltrates with eosinophilia.
Zimmermann N; Wikenheiser-Brokamp KA
Ann Allergy Asthma Immunol; 2018 Aug; 121(2):179-185. PubMed ID: 29803709
[TBL] [Abstract][Full Text] [Related]
5. World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2015 Nov; 90(11):1077-89. PubMed ID: 26486351
[TBL] [Abstract][Full Text] [Related]
6. World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2012 Sep; 87(9):903-14. PubMed ID: 22926771
[TBL] [Abstract][Full Text] [Related]
7. World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2011 Aug; 86(8):677-88. PubMed ID: 21761433
[TBL] [Abstract][Full Text] [Related]
8. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
[TBL] [Abstract][Full Text] [Related]
9. World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2017 Nov; 92(11):1243-1259. PubMed ID: 29044676
[TBL] [Abstract][Full Text] [Related]
10. Approach to Eosinophilia Presenting With Pulmonary Symptoms.
Rosenberg CE; Khoury P
Chest; 2021 Feb; 159(2):507-516. PubMed ID: 33002503
[TBL] [Abstract][Full Text] [Related]
11. World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.
Shomali W; Gotlib J
Am J Hematol; 2019 Oct; 94(10):1149-1167. PubMed ID: 31423623
[TBL] [Abstract][Full Text] [Related]
12. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management.
Shomali W; Gotlib J
Am J Hematol; 2022 Jan; 97(1):129-148. PubMed ID: 34533850
[TBL] [Abstract][Full Text] [Related]
13. A diagnostic protocol designed for determining allergic causes in patients with blood eosinophilia.
Magnaval JF; Laurent G; Gaudré N; Fillaux J; Berry A
Mil Med Res; 2017; 4():15. PubMed ID: 28546866
[TBL] [Abstract][Full Text] [Related]
14. Blood eosinophilia: a new paradigm in disease classification, diagnosis, and treatment.
Tefferi A
Mayo Clin Proc; 2005 Jan; 80(1):75-83. PubMed ID: 15667033
[TBL] [Abstract][Full Text] [Related]
15. Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update.
Tefferi A; Gotlib J; Pardanani A
Mayo Clin Proc; 2010 Feb; 85(2):158-64. PubMed ID: 20053713
[TBL] [Abstract][Full Text] [Related]
16. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
[TBL] [Abstract][Full Text] [Related]
17. [Current differential diagnosis of hypereosinophilic syndrome].
Dinić-Uzurov V; Lalosević V; Milosević I; Urosević I; Lalosević D; Popović S
Med Pregl; 2007; 60(11-12):581-6. PubMed ID: 18666600
[TBL] [Abstract][Full Text] [Related]
18. Eosinophilic Fasciitis - Clinical Features and Therapeutic Management.
Bilewicz-Stebel M; Bergler-Czop B; Stebel R; Weryńska-Kalemba M; Matuszewska A
Acta Dermatovenerol Croat; 2020 Dec; 28(3):190-192. PubMed ID: 33422175
[TBL] [Abstract][Full Text] [Related]
19. Sepsis Care Pathway 2019.
Labib A
Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
[No Abstract] [Full Text] [Related]
20. Causes of hypereosinophilia in 100 consecutive patients.
Moller D; Tan J; Gauiran DTV; Medvedev N; Hudoba M; Carruthers MN; Dehghan N; van den Berghe J; Bruyère H; Chen LYC
Eur J Haematol; 2020 Sep; 105(3):292-301. PubMed ID: 32364630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
